Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$388K Buy
+28,649
New +$419K 0.06% 583
2026
Q1
Sell
-44,151
Closed -$775K 1215
2025
Q4
$775K Sell
44,151
-57,247
-56% -$998K 0.12% 314
2025
Q3
$1.6M Buy
101,398
+31,292
+45% +$402K 0.25% 72
2025
Q2
$758K Buy
70,106
+57,774
+468% +$562K 0.13% 291
2025
Q1
$132K Buy
12,332
+1,128
+10% +$14.8K 0.02% 846
2024
Q4
$169K Sell
11,204
-39,681
-78% -$534K 0.03% 771
2024
Q3
$625K Buy
+50,885
New +$646K 0.14% 261
2023
Q4
Sell
-13,642
Closed -$176K 1005
2023
Q3
$176K Buy
+13,642
New +$202K 0.05% 582
2023
Q2
Sell
-12,890
Closed -$253K 940
2023
Q1
$253K Buy
+12,890
New +$246K 0.08% 462
2022
Q1
Sell
-6,921
Closed -$206K 685
2021
Q4
$206K Sell
6,921
-17,558
-72% -$558K 0.12% 360
2021
Q3
$792K Buy
+24,479
New +$882K 0.5% 17
2021
Q2
Sell
-7,585
Closed -$284K 434
2021
Q1
$284K Sell
7,585
-1,020
-12% -$34.4K 0.51% 81
2020
Q4
$201K Buy
+8,605
New +$160K 0.41% 154

Other funds holding SONO

Fox Run Management's SONO Position: Q2 2026 in Review

Fox Run Management opened a new position in Sonos (SONO) in Q2 2026: 28,649 shares worth $388K. The stake represents 0.06% of the portfolio and ranks #583 among its holdings. This is a return to the name: Fox Run Management previously reported a position in SONO as recently as Q4 2025.

Fox Run Management first reported a position in SONO in Q4 2020 and has held it in 13 quarters since. The position peaked at $1.6M in Q3 2025. 305 funds tracked by Wall St. Rank hold SONO as of Q2 2026.

  • Fox Run Management held 28,649 shares of Sonos worth $388K as of Q2 2026.
  • Sonos was a new Fox Run Management position in Q2 2026.
  • Sonos made up 0.06% of Fox Run Management's portfolio in Q2 2026, its #583 holding.
  • Fox Run Management first reported a position in Sonos in Q4 2020 and has held it in 13 quarters since.
  • Fox Run Management's Sonos position peaked at $1.6M in Q3 2025.
  • 305 funds tracked by Wall St. Rank held Sonos as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.